Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Doubling Down on Headache Pain: Effective Combo of Common Drugs
    Health

    Doubling Down on Headache Pain: Effective Combo of Common Drugs

    By American Academy of NeurologyJune 19, 2021No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Main With Headache
    A combination of two common anti-nausea medications may alleviate headaches following trauma, such as a fall, assault, or car accident.

    Study says combo of common drugs may provide headache relief after injury.

    It’s not uncommon for people who experience a concussion to have moderate to severe headaches in the weeks after the injury. A new study has found a combination of two drugs, both common anti-nausea medications, given intravenously in the emergency room may relieve those headaches better than a placebo. The study is published in Neurology®, the medical journal of the American Academy of Neurology.

    Metoclopramide and Diphenhydramine: A Dual-Action Strategy

    Metoclopramide is an anti-nausea medicine sometimes used to treat migraine. Diphenhydramine is a common antihistamine that when used in its injected form can treat motion sickness. Higher doses of metoclopramide given intravenously can cause restlessness, so this study combined diphenhydramine with metoclopramide to prevent those symptoms.

    “The headaches you get after a trauma like a fall, an assault, or car accident can linger for months or even years and lead to a reduced quality of life, so the results of our study are promising,” said study author Benjamin W. Friedman, M.D., of Albert Einstein College of Medicine, Bronx, N.Y.

    The study involved 160 people who experienced head trauma and then visited an emergency room because of a headache within 10 days. They were randomly assigned to two groups: 81 people were given 20 milligrams (mg) of metoclopramide and 25 mg of diphenhydramine intravenously. The remaining 79 people were given an injection of saline solution as a placebo.

    Researchers asked people to rate the intensity of their pain on a scale of zero to 10 one hour after the medication was administered. On this scale, zero means no pain and 10 means the worst pain imaginable.

    The study found that the drug combination reduced the average person’s pain level by more than five points one hour later. People in the group given the combination of metoclopramide and diphenhydramine said they improved, on average, by 5.2 points on the pain scale. People in the group given a placebo, on average, said their pain improved by 3.8 points on the pain scale.

    Side Effects

    In the group given the drug combination, 43% experienced side effects like drowsiness, restlessness, or diarrhea. In the group given the placebo, 28% of the people reported those kinds of side effects.

    “More research is needed to determine the most effective dose of metoclopramide, and how long to administer it, to see if people can get longer-term relief after they leave the emergency room,” Friedman said. “Also, future work may be able to determine whether early treatment with this medication can target other disruptive symptoms you may get after a head injury, like depression, sleep disorders, and anxiety.”

    A limitation of the study is that the study participants came from high-poverty areas of the country, and may have had less access to care. Because successful headache treatment may be associated with access to care, these results may not apply to the general population.

    Reference: “Randomized Study of Metoclopramide Plus Diphenhydramine for Acute Posttraumatic Headache” by Benjamin W. Friedman, Eddie Irizarry, Darnell Cain, Arianna Caradonna, Mia T. Minen, Clemencia Solorzano, Eleftheria Zias, David Zybert, Michael McGregor, Polly E. Bijur and E. John Gallagher, 24 March 2021, Neurology.
    DOI: 10.1212/WNL.0000000000011822

    The study received support from the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    American Academy of Neurology Neuroscience Pain Management
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Burning, Tingling and Pain in Your Feet? You May Have Small Fiber Neuropathy

    A Ketogenic Diet May Be Helpful With Brain Cancer

    Brain Shrinkage: Your Neighborhood May Affect Your Brain Health

    50% of Kids With Inflammatory Syndrome After COVID-19 Have Neurological Symptoms

    Loss of Sense of Smell and Taste May Last Up to 5 Months After COVID-19 Infection

    Pioneering Sensory Neuron Replication: New Technique to Fast-Track Pain Research

    Neurologic Complications From COVID-19 Are Common – Even in Moderate Cases of the Disease

    Even in People With Parkinson’s Gene, Coffee May Help Protect Against the Disease

    Analyzing Brain Activity to Detect and Treat Patient Pain Even When Unconscious

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years

    Natural Compound Shows Powerful Potential Against Rheumatoid Arthritis

    100,000-Year-Old Neanderthal Fossils in Poland Reveal Unexpected Genetic Connections

    Simple “Gut Reset” May Prevent Weight Gain After Ozempic or Wegovy

    2.8 Days to Disaster: Scientists Warn Low Earth Orbit Could Suddenly Collapse

    Common Food Compound Shows Surprising Power Against Superbugs

    5 Simple Ways To Remember More and Forget Less

    The Atomic Gap That Could Cost the Semiconductor Industry Billions

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Print Artificial Neurons That Can Talk to the Brain
    • Bowel and Ovarian Cancers Are Dramatically Rising in Young Adults and Scientists Aren’t Sure Why
    • Alzheimer’s May Begin Decades Earlier Than You Think, New Mayo Clinic Study Finds
    • The Hidden Risk of Taking Breaks From Weight-Loss Drugs Like Ozempic
    • Total Solar Eclipse Made Cities Go Eerily Quiet Beneath the Surface
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.